Northern Trust Corp Ligand Pharmaceuticals Inc Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

A detailed history of Northern Trust Corp transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Northern Trust Corp holds 262,750 shares of LGND stock, worth $30.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
262,750
Previous 204,903 28.23%
Holding current value
$30.1 Million
Previous $17.3 Million 52.44%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$82.7 - $110.11 $4.78 Million - $6.37 Million
57,847 Added 28.23%
262,750 $26.3 Million
Q2 2024

Aug 14, 2024
SELL
$68.53 - $87.91 $368,896 - $473,219
-5,383 Reduced 2.56%
204,903 $17.3 Million
Q1 2024

May 14, 2024
SELL
$68.64 - $89.2 $651,668 - $846,864
-9,494 Reduced 4.32%
210,286 $15.4 Million
Q4 2023

Feb 13, 2024
SELL
$49.57 - $72.63 $5,006 - $7,335
-101 Reduced 0.05%
219,780 $15.7 Million
Q3 2023

Nov 13, 2023
BUY
$58.86 - $72.67 $92,763 - $114,527
1,576 Added 0.72%
219,881 $13.2 Million
Q2 2023

Aug 11, 2023
BUY
$69.53 - $79.33 $1.09 Million - $1.25 Million
15,714 Added 7.76%
218,305 $15.7 Million
Q1 2023

May 15, 2023
SELL
$65.67 - $77.08 $45,049 - $52,876
-686 Reduced 0.34%
202,591 $14.9 Million
Q4 2022

Feb 13, 2023
BUY
$61.72 - $96.74 $1.86 Million - $2.92 Million
30,164 Added 17.42%
203,277 $13.6 Million
Q3 2022

Nov 14, 2022
SELL
$0.01 - $107.56 $241 - $2.59 Million
-24,108 Reduced 12.22%
173,113 $14.9 Million
Q2 2022

Aug 12, 2022
SELL
$74.52 - $117.06 $372,078 - $584,480
-4,993 Reduced 2.47%
197,221 $17.6 Million
Q1 2022

May 13, 2022
SELL
$94.99 - $151.56 $3.24 Million - $5.17 Million
-34,090 Reduced 14.43%
202,214 $22.7 Million
Q4 2021

Feb 08, 2022
SELL
$127.69 - $165.85 $317,437 - $412,303
-2,486 Reduced 1.04%
236,304 $36.5 Million
Q3 2021

Nov 15, 2021
SELL
$102.33 - $144.73 $4.78 Million - $6.76 Million
-46,715 Reduced 16.36%
238,790 $33.3 Million
Q2 2021

Aug 13, 2021
BUY
$113.03 - $155.64 $5.7 Million - $7.85 Million
50,450 Added 21.46%
285,505 $37.5 Million
Q1 2021

May 12, 2021
SELL
$99.52 - $215.83 $786,407 - $1.71 Million
-7,902 Reduced 3.25%
235,055 $35.8 Million
Q4 2020

Feb 11, 2021
SELL
$80.55 - $106.05 $1.97 Million - $2.59 Million
-24,396 Reduced 9.13%
242,957 $24.2 Million
Q3 2020

Nov 16, 2020
SELL
$89.56 - $126.72 $2.73 Million - $3.86 Million
-30,499 Reduced 10.24%
267,353 $25.5 Million
Q2 2020

Aug 14, 2020
BUY
$68.28 - $123.65 $77,907 - $141,084
1,141 Added 0.38%
297,852 $33.3 Million
Q1 2020

May 14, 2020
SELL
$63.37 - $107.88 $459,495 - $782,237
-7,251 Reduced 2.39%
296,711 $21.6 Million
Q4 2019

Feb 14, 2020
SELL
$96.94 - $113.59 $2.87 Million - $3.36 Million
-29,604 Reduced 8.88%
303,962 $31.7 Million
Q3 2019

Nov 13, 2019
SELL
$86.25 - $120.16 $1.71 Million - $2.39 Million
-19,874 Reduced 5.62%
333,566 $33.2 Million
Q2 2019

Aug 13, 2019
SELL
$107.38 - $129.34 $2.37 Million - $2.86 Million
-22,102 Reduced 5.89%
353,440 $40.3 Million
Q1 2019

May 13, 2019
BUY
$105.93 - $142.47 $1.18 Million - $1.59 Million
11,130 Added 3.05%
375,542 $47.2 Million
Q4 2018

Feb 12, 2019
BUY
$128.36 - $272.13 $6.54 Million - $13.9 Million
50,932 Added 16.25%
364,412 $49.5 Million
Q3 2018

Nov 14, 2018
BUY
$211.18 - $274.49 $492,682 - $640,385
2,333 Added 0.75%
313,480 $86 Million
Q2 2018

Sep 18, 2018
SELL
$150.77 - $207.98 $202,333 - $279,109
-1,342 Reduced 0.43%
311,147 $64.5 Million
Q2 2018

Aug 14, 2018
BUY
$150.77 - $207.98 $497,993 - $686,957
3,303 Added 1.07%
312,489 $64.7 Million
Q1 2018

May 09, 2018
SELL
$138.63 - $182.62 $332,434 - $437,922
-2,398 Reduced 0.77%
309,186 $51.1 Million
Q4 2017

Feb 14, 2018
SELL
$128.36 - $147.04 $429,877 - $492,436
-3,349 Reduced 1.06%
311,584 $42.7 Million
Q3 2017

Nov 13, 2017
BUY
$120.91 - $137.94 $38.1 Million - $43.4 Million
314,933
314,933 $42.9 Million

Others Institutions Holding LGND

# of Institutions
256
Shares Held
18.1M
Call Options Held
26.8K
Put Options Held
9.3K
View Full List

About LIGAND PHARMACEUTICALS INC

LGND Quotes by TradingView
  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.94B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email